Daniela Russo

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 185 publications

Left Atrial Appendage Occlusion in the Era of Minimalist Approaches: Anesthesia and Imaging Considerations.

Left Atrial Appendage Occlusion in the Era of Minimalist Approaches: Anesthesia and Imaging Considerations.

Journal: Journal of clinical medicine

Published: April 03, 2026

Aglianico Grape Pomace Extract Reduces Cardiac Pacemaker Activity by Decreasing Hyperpolarization-Activated Current Density Independently of cAMP Signaling.

Aglianico Grape Pomace Extract Reduces Cardiac Pacemaker Activity by Decreasing Hyperpolarization-Activated Current Density Independently of cAMP Signaling.

Journal: Life (Basel, Switzerland)

Published: April 03, 2026

Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic.

Somatic BRCA1 and BRCA2 detection in homologous recombination deficiency testing: concordance of four sequencing workflows with the Myriad myChoice companion diagnostic.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 17, 2026

Augmented Prediction of N Parameter in Breast Cancer: Is It Possible with Shear-Wave Elastography Ultrasound Radiomics?

Augmented Prediction of N Parameter in Breast Cancer: Is It Possible with Shear-Wave Elastography Ultrasound Radiomics?

Journal: Cancers

Published: January 22, 2026

From waste to value: A systematic review of phytochemicals and functional properties of common bean (Phaseolus vulgaris L.) by-products.

From waste to value: A systematic review of phytochemicals and functional properties of common bean (Phaseolus vulgaris L.) by-products.

Journal: Food chemistry

Published: December 05, 2025

A Weakly Supervised Approach for HPV Status Prediction in Oropharyngeal Carcinoma from H&E-Stained Slides.

A Weakly Supervised Approach for HPV Status Prediction in Oropharyngeal Carcinoma from H&E-Stained Slides.

Journal: Cancers

Published: November 08, 2025

Exploring Salicornia species as potential health-promoting food: chemical fingerprinting and assessment of their bioactivities.

Exploring Salicornia species as potential health-promoting food: chemical fingerprinting and assessment of their bioactivities.

Journal: Journal of the science of food and agriculture

Published: October 15, 2025

Editorial: Regulated cell death (RCD) in cancer: signaling pathways activated by natural products and their nano-formulations.

Editorial: Regulated cell death (RCD) in cancer: signaling pathways activated by natural products and their nano-formulations.

Journal: Frontiers in pharmacology

Published: August 04, 2025

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC.

Journal: Cancer research communications

Published: August 04, 2025

CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

Journal: Cell death discovery

Published: July 30, 2025

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.

Journal: ESMO open

Published: July 02, 2025

Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.

Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.

Journal: NPJ precision oncology

Published: June 05, 2025

Showing 1-12 of 185

Last Updated: 09/26/2026